 | • レポートコード：MRC2Q12-18199 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、87ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療機器＆消耗品 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| コロナ禍により、試薬用エプコリタマブの世界市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に試薬用エプコリタマブのグローバル市場のxxx％を占める「0～100ug」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「大学」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 試薬用エプコリタマブの中国市場規模は2021年にUS$xxxと分析されており、アメリカとヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。アメリカの割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの試薬用エプコリタマブ市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 試薬用エプコリタマブのグローバル主要プレイヤーには、ProteoGenix、Thermo Fisher Scientific、Wuhan Chemstan Biotechnology、Biochempartner、AntibodySystem SASなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 試薬用エプコリタマブ市場は、種類と用途によって区分されます。世界の試薬用エプコリタマブ市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 0～100ug、100ug～1mg、1mg以上 【用途別セグメント】 大学、研究機関、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 試薬用エプコリタマブ製品概要 - 種類別市場（0～100ug、100ug～1mg、1mg以上） - 用途別市場（大学、研究機関、その他） - 調査の目的 ・エグゼクティブサマリー - 世界の試薬用エプコリタマブ販売量予測2017-2028 - 世界の試薬用エプコリタマブ売上予測2017-2028 - 試薬用エプコリタマブの地域別販売量 - 試薬用エプコリタマブの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別試薬用エプコリタマブ販売量 - 主要メーカー別試薬用エプコリタマブ売上 - 主要メーカー別試薬用エプコリタマブ価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（0～100ug、100ug～1mg、1mg以上） - 試薬用エプコリタマブの種類別販売量 - 試薬用エプコリタマブの種類別売上 - 試薬用エプコリタマブの種類別価格 ・用途別市場規模（大学、研究機関、その他） - 試薬用エプコリタマブの用途別販売量 - 試薬用エプコリタマブの用途別売上 - 試薬用エプコリタマブの用途別価格 ・北米市場 - 北米の試薬用エプコリタマブ市場規模（種類別、用途別） - 主要国別の試薬用エプコリタマブ市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの試薬用エプコリタマブ市場規模（種類別、用途別） - 主要国別の試薬用エプコリタマブ市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の試薬用エプコリタマブ市場規模（種類別、用途別） - 主要国別の試薬用エプコリタマブ市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の試薬用エプコリタマブ市場規模（種類別、用途別） - 主要国別の試薬用エプコリタマブ市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの試薬用エプコリタマブ市場規模（種類別、用途別） - 主要国別の試薬用エプコリタマブ市場規模（トルコ、サウジアラビア） ・企業情報 ProteoGenix、Thermo Fisher Scientific、Wuhan Chemstan Biotechnology、Biochempartner、AntibodySystem SAS ・産業チェーン及び販売チャネル分析 - 試薬用エプコリタマブの産業チェーン分析 - 試薬用エプコリタマブの原材料 - 試薬用エプコリタマブの生産プロセス - 試薬用エプコリタマブの販売及びマーケティング - 試薬用エプコリタマブの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 試薬用エプコリタマブの産業動向 - 試薬用エプコリタマブのマーケットドライバー - 試薬用エプコリタマブの課題 - 試薬用エプコリタマブの阻害要因 ・主な調査結果 |
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Reagent Grade Epcoritamab is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Reagent Grade Epcoritamab is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Reagent Grade Epcoritamab is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key manufacturers of Reagent Grade Epcoritamab include ProteoGenix, Thermo Fisher Scientific, Wuhan Chemstan Biotechnology, Biochempartner and AntibodySystem SAS, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers’ production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Reagent Grade Epcoritamab manufacturers, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Reagent Grade Epcoritamab market. Further, it explains the major drivers and regional dynamics of the global Reagent Grade Epcoritamab market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
ProteoGenix
Thermo Fisher Scientific
Wuhan Chemstan Biotechnology
Biochempartner
AntibodySystem SAS
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by product specification and by application segments based on sales, price, and value for the period 2017-2028.
Reagent Grade Epcoritamab Segment by Product Specification
0 – 100ug
100ug – 1mg
Above 1mg
Reagent Grade Epcoritamab Segment by Application
University
Research Institutions
Others
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Reagent Grade Epcoritamab market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Reagent Grade Epcoritamab, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Reagent Grade Epcoritamab, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Reagent Grade Epcoritamab, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Reagent Grade Epcoritamab sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Reagent Grade Epcoritamab market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Reagent Grade Epcoritamab sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including ProteoGenix, Thermo Fisher Scientific, Wuhan Chemstan Biotechnology, Biochempartner and AntibodySystem SAS, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Reagent Grade Epcoritamab in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Reagent Grade Epcoritamab manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by product specification, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by product specification, by application and by country, sales and revenue for each segment.
Chapter 8: Asia Pacific by product specification, by application and by country, sales and revenue for each segment.
Chapter 9: Latin America by product specification, by application and by country, sales and revenue for each segment.
Chapter 10: Middle East and Africa by product specification, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Reagent Grade Epcoritamab sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
1 Study Coverage
1.1 Reagent Grade Epcoritamab Product Introduction
1.2 Market by Product Specification
1.2.1 Global Reagent Grade Epcoritamab Market Size Growth Rate by Product Specification, 2017 VS 2021 VS 2028
1.2.2 0 – 100ug
1.2.3 100ug – 1mg
1.2.4 Above 1mg
1.3 Market by Application
1.3.1 Global Reagent Grade Epcoritamab Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 University
1.3.3 Research Institutions
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Reagent Grade Epcoritamab Sales Estimates and Forecasts 2017-2028
2.2 Global Reagent Grade Epcoritamab Revenue Estimates and Forecasts 2017-2028
2.3 Global Reagent Grade Epcoritamab Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Reagent Grade Epcoritamab Sales by Region
2.4.1 Global Reagent Grade Epcoritamab Sales by Region (2017-2022)
2.4.2 Global Sales Reagent Grade Epcoritamab by Region (2023-2028)
2.5 Global Reagent Grade Epcoritamab Revenue by Region
2.5.1 Global Reagent Grade Epcoritamab Revenue by Region (2017-2022)
2.5.2 Global Reagent Grade Epcoritamab Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Reagent Grade Epcoritamab Sales by Manufacturers
3.1.1 Global Top Reagent Grade Epcoritamab Manufacturers by Sales (2017-2022)
3.1.2 Global Reagent Grade Epcoritamab Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Reagent Grade Epcoritamab in 2021
3.2 Global Reagent Grade Epcoritamab Revenue by Manufacturers
3.2.1 Global Reagent Grade Epcoritamab Revenue by Manufacturers (2017-2022)
3.2.2 Global Reagent Grade Epcoritamab Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Reagent Grade Epcoritamab Revenue in 2021
3.3 Global Reagent Grade Epcoritamab Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Reagent Grade Epcoritamab Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Reagent Grade Epcoritamab Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Product Specification
4.1 Global Reagent Grade Epcoritamab Sales by Product Specification
4.1.1 Global Reagent Grade Epcoritamab Historical Sales by Product Specification (2017-2022)
4.1.2 Global Reagent Grade Epcoritamab Forecasted Sales by Product Specification (2023-2028)
4.1.3 Global Reagent Grade Epcoritamab Sales Market Share by Product Specification (2017-2028)
4.2 Global Reagent Grade Epcoritamab Revenue by Product Specification
4.2.1 Global Reagent Grade Epcoritamab Historical Revenue by Product Specification (2017-2022)
4.2.2 Global Reagent Grade Epcoritamab Forecasted Revenue by Product Specification (2023-2028)
4.2.3 Global Reagent Grade Epcoritamab Revenue Market Share by Product Specification (2017-2028)
4.3 Global Reagent Grade Epcoritamab Price by Product Specification
4.3.1 Global Reagent Grade Epcoritamab Price by Product Specification (2017-2022)
4.3.2 Global Reagent Grade Epcoritamab Price Forecast by Product Specification (2023-2028)
5 Market Size by Application
5.1 Global Reagent Grade Epcoritamab Sales by Application
5.1.1 Global Reagent Grade Epcoritamab Historical Sales by Application (2017-2022)
5.1.2 Global Reagent Grade Epcoritamab Forecasted Sales by Application (2023-2028)
5.1.3 Global Reagent Grade Epcoritamab Sales Market Share by Application (2017-2028)
5.2 Global Reagent Grade Epcoritamab Revenue by Application
5.2.1 Global Reagent Grade Epcoritamab Historical Revenue by Application (2017-2022)
5.2.2 Global Reagent Grade Epcoritamab Forecasted Revenue by Application (2023-2028)
5.2.3 Global Reagent Grade Epcoritamab Revenue Market Share by Application (2017-2028)
5.3 Global Reagent Grade Epcoritamab Price by Application
5.3.1 Global Reagent Grade Epcoritamab Price by Application (2017-2022)
5.3.2 Global Reagent Grade Epcoritamab Price Forecast by Application (2023-2028)
6 North America
6.1 North America Reagent Grade Epcoritamab Market Size by Product Specification
6.1.1 North America Reagent Grade Epcoritamab Sales by Product Specification (2017-2028)
6.1.2 North America Reagent Grade Epcoritamab Revenue by Product Specification (2017-2028)
6.2 North America Reagent Grade Epcoritamab Market Size by Application
6.2.1 North America Reagent Grade Epcoritamab Sales by Application (2017-2028)
6.2.2 North America Reagent Grade Epcoritamab Revenue by Application (2017-2028)
6.3 North America Reagent Grade Epcoritamab Market Size by Country
6.3.1 North America Reagent Grade Epcoritamab Sales by Country (2017-2028)
6.3.2 North America Reagent Grade Epcoritamab Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Reagent Grade Epcoritamab Market Size by Product Specification
7.1.1 Europe Reagent Grade Epcoritamab Sales by Product Specification (2017-2028)
7.1.2 Europe Reagent Grade Epcoritamab Revenue by Product Specification (2017-2028)
7.2 Europe Reagent Grade Epcoritamab Market Size by Application
7.2.1 Europe Reagent Grade Epcoritamab Sales by Application (2017-2028)
7.2.2 Europe Reagent Grade Epcoritamab Revenue by Application (2017-2028)
7.3 Europe Reagent Grade Epcoritamab Market Size by Country
7.3.1 Europe Reagent Grade Epcoritamab Sales by Country (2017-2028)
7.3.2 Europe Reagent Grade Epcoritamab Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Reagent Grade Epcoritamab Market Size by Product Specification
8.1.1 Asia Pacific Reagent Grade Epcoritamab Sales by Product Specification (2017-2028)
8.1.2 Asia Pacific Reagent Grade Epcoritamab Revenue by Product Specification (2017-2028)
8.2 Asia Pacific Reagent Grade Epcoritamab Market Size by Application
8.2.1 Asia Pacific Reagent Grade Epcoritamab Sales by Application (2017-2028)
8.2.2 Asia Pacific Reagent Grade Epcoritamab Revenue by Application (2017-2028)
8.3 Asia Pacific Reagent Grade Epcoritamab Market Size by Region
8.3.1 Asia Pacific Reagent Grade Epcoritamab Sales by Region (2017-2028)
8.3.2 Asia Pacific Reagent Grade Epcoritamab Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Reagent Grade Epcoritamab Market Size by Product Specification
9.1.1 Latin America Reagent Grade Epcoritamab Sales by Product Specification (2017-2028)
9.1.2 Latin America Reagent Grade Epcoritamab Revenue by Product Specification (2017-2028)
9.2 Latin America Reagent Grade Epcoritamab Market Size by Application
9.2.1 Latin America Reagent Grade Epcoritamab Sales by Application (2017-2028)
9.2.2 Latin America Reagent Grade Epcoritamab Revenue by Application (2017-2028)
9.3 Latin America Reagent Grade Epcoritamab Market Size by Country
9.3.1 Latin America Reagent Grade Epcoritamab Sales by Country (2017-2028)
9.3.2 Latin America Reagent Grade Epcoritamab Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Reagent Grade Epcoritamab Market Size by Product Specification
10.1.1 Middle East and Africa Reagent Grade Epcoritamab Sales by Product Specification (2017-2028)
10.1.2 Middle East and Africa Reagent Grade Epcoritamab Revenue by Product Specification (2017-2028)
10.2 Middle East and Africa Reagent Grade Epcoritamab Market Size by Application
10.2.1 Middle East and Africa Reagent Grade Epcoritamab Sales by Application (2017-2028)
10.2.2 Middle East and Africa Reagent Grade Epcoritamab Revenue by Application (2017-2028)
10.3 Middle East and Africa Reagent Grade Epcoritamab Market Size by Country
10.3.1 Middle East and Africa Reagent Grade Epcoritamab Sales by Country (2017-2028)
10.3.2 Middle East and Africa Reagent Grade Epcoritamab Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 ProteoGenix
11.1.1 ProteoGenix Corporation Information
11.1.2 ProteoGenix Overview
11.1.3 ProteoGenix Reagent Grade Epcoritamab Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 ProteoGenix Reagent Grade Epcoritamab Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 ProteoGenix Recent Developments
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Corporation Information
11.2.2 Thermo Fisher Scientific Overview
11.2.3 Thermo Fisher Scientific Reagent Grade Epcoritamab Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Thermo Fisher Scientific Reagent Grade Epcoritamab Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Thermo Fisher Scientific Recent Developments
11.3 Wuhan Chemstan Biotechnology
11.3.1 Wuhan Chemstan Biotechnology Corporation Information
11.3.2 Wuhan Chemstan Biotechnology Overview
11.3.3 Wuhan Chemstan Biotechnology Reagent Grade Epcoritamab Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Wuhan Chemstan Biotechnology Reagent Grade Epcoritamab Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Wuhan Chemstan Biotechnology Recent Developments
11.4 Biochempartner
11.4.1 Biochempartner Corporation Information
11.4.2 Biochempartner Overview
11.4.3 Biochempartner Reagent Grade Epcoritamab Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Biochempartner Reagent Grade Epcoritamab Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Biochempartner Recent Developments
11.5 AntibodySystem SAS
11.5.1 AntibodySystem SAS Corporation Information
11.5.2 AntibodySystem SAS Overview
11.5.3 AntibodySystem SAS Reagent Grade Epcoritamab Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 AntibodySystem SAS Reagent Grade Epcoritamab Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 AntibodySystem SAS Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Reagent Grade Epcoritamab Industry Chain Analysis
12.2 Reagent Grade Epcoritamab Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Reagent Grade Epcoritamab Production Mode & Process
12.4 Reagent Grade Epcoritamab Sales and Marketing
12.4.1 Reagent Grade Epcoritamab Sales Channels
12.4.2 Reagent Grade Epcoritamab Distributors
12.5 Reagent Grade Epcoritamab Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Reagent Grade Epcoritamab Industry Trends
13.2 Reagent Grade Epcoritamab Market Drivers
13.3 Reagent Grade Epcoritamab Market Challenges
13.4 Reagent Grade Epcoritamab Market Restraints
14 Key Findings in The Global Reagent Grade Epcoritamab Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
Table 1. Global Reagent Grade Epcoritamab Market Size Growth Rate by Product Specification, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of 0 - 100ug
Table 3. Major Manufacturers of 100ug - 1mg
Table 4. Major Manufacturers of Above 1mg
Table 5. Global Reagent Grade Epcoritamab Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Reagent Grade Epcoritamab Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Reagent Grade Epcoritamab Sales by Region (2017-2022) & (Kg)
Table 8. Global Reagent Grade Epcoritamab Sales Market Share by Region (2017-2022)
Table 9. Global Reagent Grade Epcoritamab Sales by Region (2023-2028) & (Kg)
Table 10. Global Reagent Grade Epcoritamab Sales Market Share by Region (2023-2028)
Table 11. Global Reagent Grade Epcoritamab Revenue by Region (2017-2022) & (US$ Million)
Table 12. Global Reagent Grade Epcoritamab Revenue Market Share by Region (2017-2022)
Table 13. Global Reagent Grade Epcoritamab Revenue by Region (2023-2028) & (US$ Million)
Table 14. Global Reagent Grade Epcoritamab Revenue Market Share by Region (2023-2028)
Table 15. Global Reagent Grade Epcoritamab Sales by Manufacturers (2017-2022) & (Kg)
Table 16. Global Reagent Grade Epcoritamab Sales Share by Manufacturers (2017-2022)
Table 17. Global Reagent Grade Epcoritamab Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 18. Global Reagent Grade Epcoritamab Revenue Share by Manufacturers (2017-2022)
Table 19. Reagent Grade Epcoritamab Price by Manufacturers (2017-2022) &(US$/Kg)
Table 20. Global Reagent Grade Epcoritamab Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 21. Global Reagent Grade Epcoritamab by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Reagent Grade Epcoritamab as of 2021)
Table 22. Reagent Grade Epcoritamab Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Reagent Grade Epcoritamab Product Offered
Table 24. Date of Manufacturers Enter into Reagent Grade Epcoritamab Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Reagent Grade Epcoritamab Sales by Product Specification (2017-2022) & (Kg)
Table 27. Global Reagent Grade Epcoritamab Sales by Product Specification (2023-2028) & (Kg)
Table 28. Global Reagent Grade Epcoritamab Sales Share by Product Specification (2017-2022)
Table 29. Global Reagent Grade Epcoritamab Sales Share by Product Specification (2023-2028)
Table 30. Global Reagent Grade Epcoritamab Revenue by Product Specification (2017-2022) & (US$ Million)
Table 31. Global Reagent Grade Epcoritamab Revenue by Product Specification (2023-2028) & (US$ Million)
Table 32. Global Reagent Grade Epcoritamab Revenue Share by Product Specification (2017-2022)
Table 33. Global Reagent Grade Epcoritamab Revenue Share by Product Specification (2023-2028)
Table 34. Reagent Grade Epcoritamab Price by Product Specification (2017-2022) & (US$/Kg)
Table 35. Global Reagent Grade Epcoritamab Price Forecast by Product Specification (2023-2028) & (US$/Kg)
Table 36. Global Reagent Grade Epcoritamab Sales by Application (2017-2022) & (Kg)
Table 37. Global Reagent Grade Epcoritamab Sales by Application (2023-2028) & (Kg)
Table 38. Global Reagent Grade Epcoritamab Sales Share by Application (2017-2022)
Table 39. Global Reagent Grade Epcoritamab Sales Share by Application (2023-2028)
Table 40. Global Reagent Grade Epcoritamab Revenue by Application (2017-2022) & (US$ Million)
Table 41. Global Reagent Grade Epcoritamab Revenue by Application (2023-2028) & (US$ Million)
Table 42. Global Reagent Grade Epcoritamab Revenue Share by Application (2017-2022)
Table 43. Global Reagent Grade Epcoritamab Revenue Share by Application (2023-2028)
Table 44. Reagent Grade Epcoritamab Price by Application (2017-2022) & (US$/Kg)
Table 45. Global Reagent Grade Epcoritamab Price Forecast by Application (2023-2028) & (US$/Kg)
Table 46. North America Reagent Grade Epcoritamab Sales by Product Specification (2017-2022) & (Kg)
Table 47. North America Reagent Grade Epcoritamab Sales by Product Specification (2023-2028) & (Kg)
Table 48. North America Reagent Grade Epcoritamab Revenue by Product Specification (2017-2022) & (US$ Million)
Table 49. North America Reagent Grade Epcoritamab Revenue by Product Specification (2023-2028) & (US$ Million)
Table 50. North America Reagent Grade Epcoritamab Sales by Application (2017-2022) & (Kg)
Table 51. North America Reagent Grade Epcoritamab Sales by Application (2023-2028) & (Kg)
Table 52. North America Reagent Grade Epcoritamab Revenue by Application (2017-2022) & (US$ Million)
Table 53. North America Reagent Grade Epcoritamab Revenue by Application (2023-2028) & (US$ Million)
Table 54. North America Reagent Grade Epcoritamab Sales by Country (2017-2022) & (Kg)
Table 55. North America Reagent Grade Epcoritamab Sales by Country (2023-2028) & (Kg)
Table 56. North America Reagent Grade Epcoritamab Revenue by Country (2017-2022) & (US$ Million)
Table 57. North America Reagent Grade Epcoritamab Revenue by Country (2023-2028) & (US$ Million)
Table 58. Europe Reagent Grade Epcoritamab Sales by Product Specification (2017-2022) & (Kg)
Table 59. Europe Reagent Grade Epcoritamab Sales by Product Specification (2023-2028) & (Kg)
Table 60. Europe Reagent Grade Epcoritamab Revenue by Product Specification (2017-2022) & (US$ Million)
Table 61. Europe Reagent Grade Epcoritamab Revenue by Product Specification (2023-2028) & (US$ Million)
Table 62. Europe Reagent Grade Epcoritamab Sales by Application (2017-2022) & (Kg)
Table 63. Europe Reagent Grade Epcoritamab Sales by Application (2023-2028) & (Kg)
Table 64. Europe Reagent Grade Epcoritamab Revenue by Application (2017-2022) & (US$ Million)
Table 65. Europe Reagent Grade Epcoritamab Revenue by Application (2023-2028) & (US$ Million)
Table 66. Europe Reagent Grade Epcoritamab Sales by Country (2017-2022) & (Kg)
Table 67. Europe Reagent Grade Epcoritamab Sales by Country (2023-2028) & (Kg)
Table 68. Europe Reagent Grade Epcoritamab Revenue by Country (2017-2022) & (US$ Million)
Table 69. Europe Reagent Grade Epcoritamab Revenue by Country (2023-2028) & (US$ Million)
Table 70. Asia Pacific Reagent Grade Epcoritamab Sales by Product Specification (2017-2022) & (Kg)
Table 71. Asia Pacific Reagent Grade Epcoritamab Sales by Product Specification (2023-2028) & (Kg)
Table 72. Asia Pacific Reagent Grade Epcoritamab Revenue by Product Specification (2017-2022) & (US$ Million)
Table 73. Asia Pacific Reagent Grade Epcoritamab Revenue by Product Specification (2023-2028) & (US$ Million)
Table 74. Asia Pacific Reagent Grade Epcoritamab Sales by Application (2017-2022) & (Kg)
Table 75. Asia Pacific Reagent Grade Epcoritamab Sales by Application (2023-2028) & (Kg)
Table 76. Asia Pacific Reagent Grade Epcoritamab Revenue by Application (2017-2022) & (US$ Million)
Table 77. Asia Pacific Reagent Grade Epcoritamab Revenue by Application (2023-2028) & (US$ Million)
Table 78. Asia Pacific Reagent Grade Epcoritamab Sales by Region (2017-2022) & (Kg)
Table 79. Asia Pacific Reagent Grade Epcoritamab Sales by Region (2023-2028) & (Kg)
Table 80. Asia Pacific Reagent Grade Epcoritamab Revenue by Region (2017-2022) & (US$ Million)
Table 81. Asia Pacific Reagent Grade Epcoritamab Revenue by Region (2023-2028) & (US$ Million)
Table 82. Latin America Reagent Grade Epcoritamab Sales by Product Specification (2017-2022) & (Kg)
Table 83. Latin America Reagent Grade Epcoritamab Sales by Product Specification (2023-2028) & (Kg)
Table 84. Latin America Reagent Grade Epcoritamab Revenue by Product Specification (2017-2022) & (US$ Million)
Table 85. Latin America Reagent Grade Epcoritamab Revenue by Product Specification (2023-2028) & (US$ Million)
Table 86. Latin America Reagent Grade Epcoritamab Sales by Application (2017-2022) & (Kg)
Table 87. Latin America Reagent Grade Epcoritamab Sales by Application (2023-2028) & (Kg)
Table 88. Latin America Reagent Grade Epcoritamab Revenue by Application (2017-2022) & (US$ Million)
Table 89. Latin America Reagent Grade Epcoritamab Revenue by Application (2023-2028) & (US$ Million)
Table 90. Latin America Reagent Grade Epcoritamab Sales by Country (2017-2022) & (Kg)
Table 91. Latin America Reagent Grade Epcoritamab Sales by Country (2023-2028) & (Kg)
Table 92. Latin America Reagent Grade Epcoritamab Revenue by Country (2017-2022) & (US$ Million)
Table 93. Latin America Reagent Grade Epcoritamab Revenue by Country (2023-2028) & (US$ Million)
Table 94. Middle East and Africa Reagent Grade Epcoritamab Sales by Product Specification (2017-2022) & (Kg)
Table 95. Middle East and Africa Reagent Grade Epcoritamab Sales by Product Specification (2023-2028) & (Kg)
Table 96. Middle East and Africa Reagent Grade Epcoritamab Revenue by Product Specification (2017-2022) & (US$ Million)
Table 97. Middle East and Africa Reagent Grade Epcoritamab Revenue by Product Specification (2023-2028) & (US$ Million)
Table 98. Middle East and Africa Reagent Grade Epcoritamab Sales by Application (2017-2022) & (Kg)
Table 99. Middle East and Africa Reagent Grade Epcoritamab Sales by Application (2023-2028) & (Kg)
Table 100. Middle East and Africa Reagent Grade Epcoritamab Revenue by Application (2017-2022) & (US$ Million)
Table 101. Middle East and Africa Reagent Grade Epcoritamab Revenue by Application (2023-2028) & (US$ Million)
Table 102. Middle East and Africa Reagent Grade Epcoritamab Sales by Country (2017-2022) & (Kg)
Table 103. Middle East and Africa Reagent Grade Epcoritamab Sales by Country (2023-2028) & (Kg)
Table 104. Middle East and Africa Reagent Grade Epcoritamab Revenue by Country (2017-2022) & (US$ Million)
Table 105. Middle East and Africa Reagent Grade Epcoritamab Revenue by Country (2023-2028) & (US$ Million)
Table 106. ProteoGenix Corporation Information
Table 107. ProteoGenix Description and Major Businesses
Table 108. ProteoGenix Reagent Grade Epcoritamab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 109. ProteoGenix Reagent Grade Epcoritamab Product Model Numbers, Pictures, Descriptions and Specifications
Table 110. ProteoGenix Recent Developments
Table 111. Thermo Fisher Scientific Corporation Information
Table 112. Thermo Fisher Scientific Description and Major Businesses
Table 113. Thermo Fisher Scientific Reagent Grade Epcoritamab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 114. Thermo Fisher Scientific Reagent Grade Epcoritamab Product Model Numbers, Pictures, Descriptions and Specifications
Table 115. Thermo Fisher Scientific Recent Developments
Table 116. Wuhan Chemstan Biotechnology Corporation Information
Table 117. Wuhan Chemstan Biotechnology Description and Major Businesses
Table 118. Wuhan Chemstan Biotechnology Reagent Grade Epcoritamab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 119. Wuhan Chemstan Biotechnology Reagent Grade Epcoritamab Product Model Numbers, Pictures, Descriptions and Specifications
Table 120. Wuhan Chemstan Biotechnology Recent Developments
Table 121. Biochempartner Corporation Information
Table 122. Biochempartner Description and Major Businesses
Table 123. Biochempartner Reagent Grade Epcoritamab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 124. Biochempartner Reagent Grade Epcoritamab Product Model Numbers, Pictures, Descriptions and Specifications
Table 125. Biochempartner Recent Developments
Table 126. AntibodySystem SAS Corporation Information
Table 127. AntibodySystem SAS Description and Major Businesses
Table 128. AntibodySystem SAS Reagent Grade Epcoritamab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 129. AntibodySystem SAS Reagent Grade Epcoritamab Product Model Numbers, Pictures, Descriptions and Specifications
Table 130. AntibodySystem SAS Recent Developments
Table 131. Key Raw Materials Lists
Table 132. Raw Materials Key Suppliers Lists
Table 133. Reagent Grade Epcoritamab Distributors List
Table 134. Reagent Grade Epcoritamab Customers List
Table 135. Reagent Grade Epcoritamab Market Trends
Table 136. Reagent Grade Epcoritamab Market Drivers
Table 137. Reagent Grade Epcoritamab Market Challenges
Table 138. Reagent Grade Epcoritamab Market Restraints
Table 139. Research Programs/Design for This Report
Table 140. Key Data Information from Secondary Sources
Table 141. Key Data Information from Primary Sources
List of Figures
Figure 1. Reagent Grade Epcoritamab Product Picture
Figure 2. Global Reagent Grade Epcoritamab Market Share by Product Specification in 2021 & 2028
Figure 3. 0 - 100ug Product Picture
Figure 4. 100ug - 1mg Product Picture
Figure 5. Above 1mg Product Picture
Figure 6. Global Reagent Grade Epcoritamab Market Share by Application in 2021 & 2028
Figure 7. University
Figure 8. Research Institutions
Figure 9. Others
Figure 10. Reagent Grade Epcoritamab Report Years Considered
Figure 11. Global Reagent Grade Epcoritamab Sales 2017-2028 (Kg)
Figure 12. Global Reagent Grade Epcoritamab Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Reagent Grade Epcoritamab Revenue 2017-2028 (US$ Million)
Figure 14. Global Reagent Grade Epcoritamab Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 15. Global Reagent Grade Epcoritamab Sales Market Share by Region (2017-2022)
Figure 16. Global Reagent Grade Epcoritamab Sales Market Share by Region (2023-2028)
Figure 17. North America Reagent Grade Epcoritamab Sales YoY (2017-2028) & (Kg)
Figure 18. North America Reagent Grade Epcoritamab Revenue YoY (2017-2028) & (US$ Million)
Figure 19. Europe Reagent Grade Epcoritamab Sales YoY (2017-2028) & (Kg)
Figure 20. Europe Reagent Grade Epcoritamab Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Asia-Pacific Reagent Grade Epcoritamab Sales YoY (2017-2028) & (Kg)
Figure 22. Asia-Pacific Reagent Grade Epcoritamab Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Latin America Reagent Grade Epcoritamab Sales YoY (2017-2028) & (Kg)
Figure 24. Latin America Reagent Grade Epcoritamab Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Middle East & Africa Reagent Grade Epcoritamab Sales YoY (2017-2028) & (Kg)
Figure 26. Middle East & Africa Reagent Grade Epcoritamab Revenue YoY (2017-2028) & (US$ Million)
Figure 27. The Reagent Grade Epcoritamab Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 28. The Top 5 and 10 Largest Manufacturers of Reagent Grade Epcoritamab in the World: Market Share by Reagent Grade Epcoritamab Revenue in 2021
Figure 29. Global Reagent Grade Epcoritamab Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 30. Global Reagent Grade Epcoritamab Sales Market Share by Product Specification (2017-2028)
Figure 31. Global Reagent Grade Epcoritamab Revenue Market Share by Product Specification (2017-2028)
Figure 32. Global Reagent Grade Epcoritamab Sales Market Share by Application (2017-2028)
Figure 33. Global Reagent Grade Epcoritamab Revenue Market Share by Application (2017-2028)
Figure 34. North America Reagent Grade Epcoritamab Sales Market Share by Product Specification (2017-2028)
Figure 35. North America Reagent Grade Epcoritamab Revenue Market Share by Product Specification (2017-2028)
Figure 36. North America Reagent Grade Epcoritamab Sales Market Share by Application (2017-2028)
Figure 37. North America Reagent Grade Epcoritamab Revenue Market Share by Application (2017-2028)
Figure 38. North America Reagent Grade Epcoritamab Sales Share by Country (2017-2028)
Figure 39. North America Reagent Grade Epcoritamab Revenue Share by Country (2017-2028)
Figure 40. United States Reagent Grade Epcoritamab Revenue (2017-2028) & (US$ Million)
Figure 41. Canada Reagent Grade Epcoritamab Revenue (2017-2028) & (US$ Million)
Figure 42. Europe Reagent Grade Epcoritamab Sales Market Share by Product Specification (2017-2028)
Figure 43. Europe Reagent Grade Epcoritamab Revenue Market Share by Product Specification (2017-2028)
Figure 44. Europe Reagent Grade Epcoritamab Sales Market Share by Application (2017-2028)
Figure 45. Europe Reagent Grade Epcoritamab Revenue Market Share by Application (2017-2028)
Figure 46. Europe Reagent Grade Epcoritamab Sales Share by Country (2017-2028)
Figure 47. Europe Reagent Grade Epcoritamab Revenue Share by Country (2017-2028)
Figure 48. Germany Reagent Grade Epcoritamab Revenue (2017-2028) & (US$ Million)
Figure 49. France Reagent Grade Epcoritamab Revenue (2017-2028) & (US$ Million)
Figure 50. U.K. Reagent Grade Epcoritamab Revenue (2017-2028) & (US$ Million)
Figure 51. Italy Reagent Grade Epcoritamab Revenue (2017-2028) & (US$ Million)
Figure 52. Russia Reagent Grade Epcoritamab Revenue (2017-2028) & (US$ Million)
Figure 53. Asia Pacific Reagent Grade Epcoritamab Sales Market Share by Product Specification (2017-2028)
Figure 54. Asia Pacific Reagent Grade Epcoritamab Revenue Market Share by Product Specification (2017-2028)
Figure 55. Asia Pacific Reagent Grade Epcoritamab Sales Market Share by Application (2017-2028)
Figure 56. Asia Pacific Reagent Grade Epcoritamab Revenue Market Share by Application (2017-2028)
Figure 57. Asia Pacific Reagent Grade Epcoritamab Sales Share by Region (2017-2028)
Figure 58. Asia Pacific Reagent Grade Epcoritamab Revenue Share by Region (2017-2028)
Figure 59. China Reagent Grade Epcoritamab Revenue (2017-2028) & (US$ Million)
Figure 60. Japan Reagent Grade Epcoritamab Revenue (2017-2028) & (US$ Million)
Figure 61. South Korea Reagent Grade Epcoritamab Revenue (2017-2028) & (US$ Million)
Figure 62. India Reagent Grade Epcoritamab Revenue (2017-2028) & (US$ Million)
Figure 63. Australia Reagent Grade Epcoritamab Revenue (2017-2028) & (US$ Million)
Figure 64. China Taiwan Reagent Grade Epcoritamab Revenue (2017-2028) & (US$ Million)
Figure 65. Indonesia Reagent Grade Epcoritamab Revenue (2017-2028) & (US$ Million)
Figure 66. Thailand Reagent Grade Epcoritamab Revenue (2017-2028) & (US$ Million)
Figure 67. Malaysia Reagent Grade Epcoritamab Revenue (2017-2028) & (US$ Million)
Figure 68. Latin America Reagent Grade Epcoritamab Sales Market Share by Product Specification (2017-2028)
Figure 69. Latin America Reagent Grade Epcoritamab Revenue Market Share by Product Specification (2017-2028)
Figure 70. Latin America Reagent Grade Epcoritamab Sales Market Share by Application (2017-2028)
Figure 71. Latin America Reagent Grade Epcoritamab Revenue Market Share by Application (2017-2028)
Figure 72. Latin America Reagent Grade Epcoritamab Sales Share by Country (2017-2028)
Figure 73. Latin America Reagent Grade Epcoritamab Revenue Share by Country (2017-2028)
Figure 74. Mexico Reagent Grade Epcoritamab Revenue (2017-2028) & (US$ Million)
Figure 75. Brazil Reagent Grade Epcoritamab Revenue (2017-2028) & (US$ Million)
Figure 76. Argentina Reagent Grade Epcoritamab Revenue (2017-2028) & (US$ Million)
Figure 77. Middle East and Africa Reagent Grade Epcoritamab Sales Market Share by Product Specification (2017-2028)
Figure 78. Middle East and Africa Reagent Grade Epcoritamab Revenue Market Share by Product Specification (2017-2028)
Figure 79. Middle East and Africa Reagent Grade Epcoritamab Sales Market Share by Application (2017-2028)
Figure 80. Middle East and Africa Reagent Grade Epcoritamab Revenue Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Reagent Grade Epcoritamab Sales Share by Country (2017-2028)
Figure 82. Middle East and Africa Reagent Grade Epcoritamab Revenue Share by Country (2017-2028)
Figure 83. Turkey Reagent Grade Epcoritamab Revenue (2017-2028) & (US$ Million)
Figure 84. Saudi Arabia Reagent Grade Epcoritamab Revenue (2017-2028) & (US$ Million)
Figure 85. UAE Reagent Grade Epcoritamab Revenue (2017-2028) & (US$ Million)
Figure 86. Reagent Grade Epcoritamab Value Chain
Figure 87. Reagent Grade Epcoritamab Production Process
Figure 88. Channels of Distribution
Figure 89. Distributors Profiles
Figure 90. Bottom-up and Top-down Approaches for This Report
Figure 91. Data Triangulation
Figure 92. Key Executives Interviewed